Rhythm control

DRUG4 trials

Sponsors

Mayo Clinic, Ottawa Heart Institute Research Corporation, Yonsei University, National Taiwan University Hospital

Conditions

ArrhythmiaAtrial FibrillationAtrial Fibrillation, PersistentCognitive FunctionHeart Failure

Unknown Phase

Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial

CompletedNCT00578617

Mayo ClinicArrhythmia, Atrial Fibrillation

Start: 2006-09-30End: 2010-06-30Updated: 2013-01-04

Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial

CompletedNCT00578617

Mayo ClinicArrhythmia, Atrial Fibrillation

Start: 2006-09-30End: 2010-06-30Updated: 2013-01-04

Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation

CompletedNCT01420393

Ottawa Heart Institute Research CorporationAtrial Fibrillation, Heart Failure

Start: 2011-09-30End: 2021-06-30Updated: 2021-10-21

Rhythm Control of AF in Patients With Acute Stroke

Yonsei UniversityAtrial Fibrillation

Start: 2014-11-30End: 2019-08-31Target: 300Updated: 2019-03-26

Cognitive Function in Patients With Persisted Atrial Fibrillation

CompletedNCT04508491

National Taiwan University HospitalAtrial Fibrillation, Persistent, Cognitive Function

Start: 2020-11-30End: 2025-02-26Updated: 2026-01-16

Related Papers

Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial

Circulation2022-03-22161 citations

Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial).

2022-01-1925 citations

Should Catheter Ablation for Atrial Fibrillation be a Priority in Patients with Heart Failure with Reduced Ejection Fraction?

European Journal of Arrhythmia & Electrophysiology2022-01-01